Sona's 'THT' Most cancers Remedy to be Assessed for Efficacy and Potential to Act as a Catalyst to Generate Immune Responses in Analysis Research
Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Firm" or "Sona") is happy to announce an modern analysis initiative to ...
